APTOCROM Inc. (KOSDAQ:109960)

Market Cap	33.78B -63.3%
Revenue (ttm)	9.81B -40.2%
Net Income	-5.56B
EPS	-26.00
Shares Out	220.75M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,823,262
Average Volume	1,083,550
Open	193.00
Previous Close	178.00
Day's Range	160.00 - 193.00
52-Week Range	147.00 - 591.00
Beta	-0.11
RSI	38.92
Earnings Date	May 14, 2026

About APTOCROM

APTOCROM Inc. distributes pharmaceutical products in South Korea. It operates through pharmaceutical business, leasing business, and insulation divisions. The company is involved in design, manufacturing, and construction of insulation; design, manufacturing and installation of removable insulation materials; design, production, and construction of nuclear power plant special insulation; and foam glass insulation material molding and construction. It also offers medicines for the digestive system, including ijilong solution, gabespan soft capsu...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1998
• Employees: 14
• Stock Exchange: KOSDAQ
• Ticker Symbol: 109960

Financial Performance

In 2025, APTOCROM's revenue was 9.81 billion, a decrease of -40.20% compared to the previous year's 16.40 billion. Losses were -5.56 billion, -80.21% less than in 2024.